Cortice Biosciences Inc. 13D and 13G filings for CNS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-02 4:11 pm Purchase | 2024-07-29 | 13D | CNS Pharmaceuticals, Inc. CNSP | Cortice Biosciences Inc. | 11,467 5.700% | 11,467 (New Position) | Filing |